Value in Health

Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence?
pp. 433-446(14)
Authors: Sculpher, Mark; Claxton, Karl

An Aging Population—Burden or Blessing?
pp. 447-450(4)
Author: Williams, Alan

Evidence-Based Practice to Evidence-Based Policy: Do We Really Impact on Patient Care?
pp. 451-452(2)
Author: Wong, Peter K.

Understanding Patient Preferences for HIV Medications Using Adaptive Conjoint Analysis: Feasibility Assessment
pp. 453-461(9)
Authors: Beusterien, Kathleen M.; Dziekan, Kristina; Flood, Emuella; Harding, Gale; Jordan, Jamie C.

Cost-Effectiveness Analysis of Rituximab Combined with CHOP for Treatment of Diffuse Large B-Cell Lymphoma
pp. 462-470(9)
Authors: Best, Jennie H.; Hornberger, John; Proctor, Stephen J.; Omnes, Louis F.; Jost, Fred

Relationship between Initial Quetiapine Dose and Effectiveness as Reflected in Subsequent Mental Health Service Use among Patients with Schizophrenia or Bipolar Disorder
pp. 471-478(8)
Authors: Gianfrancesco, Frank; Wang, Ruey-hua; Pesa, Jacqueline

Eliciting Women's Preferences for a Training Program in Breast Self-Examination: A Conjoint Ranking Experiment
pp. 479-487(9)
Authors: Bech, Mickael; Sørensen, Jan; Lauridsen, Jørgen

Cost Savings from Intravenous Immunoglobulin Manufactured from Chromotography/Caprylate (IGIV-C) in Persons with Primary Humoral Immunodeficiency Disorder
pp. 488-494(7)
Authors: Mahadevia, Parthiv J.; Strell, John; Kunaprayoon, Dan; Gelfand, Erwin

Persistence and Adherence of Medications for Chronic Overactive Bladder/Urinary Incontinence in the California Medicaid Program
pp. 495-505(11)
Authors: Yu, Yanni F.; Nichol, Michael B.; Yu, Andrew P.; Ahn, Jeonghoon

Cost and Utilization Impacts of Oral Antihistamines in the California Medi-Cal Program
pp. 506-516(11)
Authors: Hay, Joel W.; Leahy, Michael